Skoglund G, Hussain M A, Holz G G
Laboratory of Physiology, Faculty of Medicine, Pitie Salpetriere, INSERM CJF.
Diabetes. 2000 Jul;49(7):1156-64. doi: 10.2337/diabetes.49.7.1156.
Glucagon-like peptide 1 (GLP-1), a hormonal activator of adenyl cyclase, stimulates insulin gene transcription, an effect mediated by the cAMP response element (CRE) of the rat insulin I gene promoter (RIP1). Here we demonstrate that the signaling mechanism underlying stimulatory effects of GLP-1 on insulin gene transcription results from protein kinase A (PKA)-independent activation of the RIP1 CRE. Although GLP-1 stimulates cAMP production in rat INS-1 insulinoma cells, we find accompanying activation of a -410-bp RIP1 luciferase construct (-410RIP1-LUC) to exist independently of this second messenger. GLP-1 produced a dose-dependent stimulation of -410RIP1-LUC (EC50 0.43 nmol/l), an effect reproduced by the GLP-1 receptor agonist exendin-4 and abolished by the antagonist exendin(9-39). Activation of RIP1 by GLP-1 was not affected by cotransfection with dominant-negative Gs alpha, was not blocked by cAMP antagonist Rp-cAMPS, and was insensitive to PKA antagonist H-89. Truncation of -410RIP1-LUC to generate -307-, -206-, and -166-bp constructs revealed 2 segments of RIP1 targeted by GLP-1. The first segment, not regulated by forskolin, was located between -410 and -307 bp of the promoter. The second segment, regulated by both GLP-1 and forskolin, included the CRE and was located between -206 and -166 bp. Consistent with these observations, stimulatory effects of GLP-1 at RIP1 were reduced after introduction of delta-182 and delta-183/180 inactivating deletions at the CRE. The action of GLP-1 at -410RIP1-LUC was also reduced by cotransfection with A-CREB, a genetically engineered isoform of the CRE binding protein CREB, which dimerizes with and prevents binding of basic-region-leucine-zipper (bZIP) transcription factors to the CRE. In contrast, the action of GLP-1 at the CRE was not blocked by cotransfection with M1-CREB, an isoform that lacks a consensus serine residue serving as substrate for PKA-mediated phosphorylation. On the basis of these studies, it is proposed that PKA-independent stimulatory actions of GLP-1 at RIP1 are mediated by bZIP transcription factors related in structure but not identical to CREB.
胰高血糖素样肽1(GLP-1)是一种腺苷酸环化酶的激素激活剂,可刺激胰岛素基因转录,该效应由大鼠胰岛素I基因启动子(RIP1)的cAMP反应元件(CRE)介导。在此我们证明,GLP-1对胰岛素基因转录的刺激作用背后的信号传导机制源于RIP1 CRE的蛋白激酶A(PKA)非依赖性激活。尽管GLP-1可刺激大鼠INS-1胰岛素瘤细胞中的cAMP产生,但我们发现伴随的-410 bp RIP1荧光素酶构建体(-410RIP1-LUC)的激活独立于这种第二信使而存在。GLP-1对-410RIP1-LUC产生剂量依赖性刺激(EC50为0.43 nmol/l),GLP-1受体激动剂艾塞那肽-4可重现该效应,而拮抗剂艾塞那肽(9-39)可消除该效应。GLP-1对RIP1的激活不受共转染显性负性Gsα的影响,不受cAMP拮抗剂Rp-cAMPS的阻断,且对PKA拮抗剂H-89不敏感。将-410RIP1-LUC截短以生成-307 bp、-206 bp和-166 bp的构建体,揭示了RIP1被GLP-1靶向的2个区段。第一个区段不受福斯可林调节,位于启动子的-410至-307 bp之间。第二个区段受GLP-1和福斯可林两者调节,包括CRE,位于-206至-166 bp之间。与这些观察结果一致,在CRE处引入δ-182和δ-183/180失活缺失后,GLP-1在RIP1处的刺激作用减弱。与cAMP反应元件结合蛋白CREB的基因工程异构体A-CREB共转染也降低了GLP-1在-410RIP1-LUC处的作用,A-CREB与碱性区域-亮氨酸拉链(bZIP)转录因子二聚化并阻止其与CRE结合。相反,与M1-CREB共转染并未阻断GLP-1在CRE处的作用,M1-CREB是一种缺乏作为PKA介导磷酸化底物的共有丝氨酸残基的异构体。基于这些研究,有人提出GLP-1在RIP1处的PKA非依赖性刺激作用由结构相关但与CREB不同的bZIP转录因子介导。